ASHP therapeutic position statement on optimizing treatment of hypertension

被引：0
|
作者：
不详
机构：
来源：
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY | 2000年 / 57卷 / 02期
关键词：
American Society of Health-System Pharmacists; angiotensin converting enzyme inhibitors; calcium antagonists; diuretics; hypertension; protocols; sympatholytics agents;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：162 / 173
页数：12
相关论文
共 50 条
  • [31] ASHP Statement on Reporting Medical Errors
    不详
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2000, 57 (16) : 1531 - 1532
  • [32] Optimizing observer performance of clinic blood Pressure measurement: a position statement from the Lancet Commission on Hypertension Group
    Padwal, Raj
    Campbell, Norm R. C.
    Schutte, Aletta E.
    Olsen, Michael Hecht
    Delles, Christian
    Etyang, Anthony
    Cruickshank, J. Kennedy
    Stergiou, George
    Rakotz, Michael K.
    Wozniak, Gregory
    Jaffe, Marc G.
    Benjamin, Ivor
    Parati, Gianfranco
    Sharman, James E.
    REVISTA PANAMERICANA DE SALUD PUBLICA-PAN AMERICAN JOURNAL OF PUBLIC HEALTH, 2020, 44
  • [33] Optimizing observer performance of clinic blood pressure measurement: a position statement from the Lancet Commission on Hypertension Group
    Padwal, Raj
    Campbell, Norm R. C.
    Schutte, Aletta E.
    Olsen, Michael Hecht
    Delles, Christian
    Etyang, Anthony
    Cruickshank, J. Kennedy
    Stergiou, George
    Rakotz, Michael K.
    Wozniak, Gregory
    Jaffe, Marc G.
    Benjamin, Ivor
    Parati, Gianfranco
    Sharman, James E.
    JOURNAL OF HYPERTENSION, 2019, 37 (09) : 1737 - 1745
  • [34] ASHP Statement on Leadership as a Professional Obligation
    Espinosa, Ashley Mains
    Mehta, Arpit
    Vlasimsky, Tara Behring
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2024, 81 (05) : e148 - e150
  • [35] ASHP Statement on Pharmacist Prescribing of Statins
    Marrs, Joel C.
    Haidar, Cyrine-Eliana
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2022, : 2182 - 2184
  • [36] ASHP Statement on Precepting as a Professional Obligation
    Wisniewski, Jennifer N.
    Williams, Charlene R.
    Carroll, Dana G.
    Richter, Lisa M.
    Eudaley, Sarah
    Kido, Kazuhiko
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2024, 81 (01) : E53 - E57
  • [37] ASHP Statement on Telehealth Pharmacy Practice
    Begnoche, Brendan R.
    Butler, C. David
    Carson, Paige H.
    Darr, Andrea
    Jenkins, Matthew T.
    Le, Trinh
    McDaniel, Robert B.
    Mourad, Hesham
    Shipman, Colleen J.
    Stratton, Timothy P.
    Tran, Kelvin
    Wong, Kong
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2022, : 1728 - 1735
  • [38] ASHP STATEMENT ON INSTITUTIONAL PHARMACY RESEARCH
    不详
    AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1985, 42 (08): : 1803 - 1803
  • [39] ASHP STATEMENT ON NATIONAL HEALTH INSURANCE
    不详
    AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1972, 29 (02): : 157 - &
  • [40] Diabetes and Hypertension: A Position Statement by the American Diabetes Association
    de Boer, Ian H.
    Bangalore, Sripal
    Benetos, Athanase
    Davis, Andrew M.
    Michos, Erin D.
    Muntner, Paul
    Rossing, Peter
    Zoungas, Sophia
    Bakris, George
    DIABETES CARE, 2017, 40 (09) : 1273 - 1284
12345